Literature DB >> 12187201

Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care.

William M Murphy1, Kimiko Takezawa, Nicholas A Maruniak.   

Abstract

PURPOSE: Morphological classifications designed by experts to stratify neoplasms according to biological potential must define categories that are reproducible among practitioners or the schemes actually create the heterogeneous populations that they seek to avoid. The application of the 1998 World Health Organization/International Society of Urologic Pathology scheme for urothelial neoplasms was studied in a community practice setting. We documented interpretive discrepancies for each category of neoplasm and determined whether a period of pathologist education may have a positive effect on the frequency of discrepant interpretations. The results suggest that patients may benefit from modifying the classification system.
MATERIALS AND METHODS: A consecutive series of specimens was divided into learning and study sets that were each independently examined by 3 pathologists. Specimens in the learning set were interpreted without previous structured education, while those in the study set were interpreted immediately after intensive education. Interpretations for each specimen were compared and interpretive discrepancies were analyzed.
RESULTS: Case distribution after education was similar among the pathologists but interpretations for any particular specimen often differed. The level of interpretive discrepancies varied according to the morphological similarity among categories in the classification scheme and was not necessarily decreased by education. When pathologists were required to discriminate between papillary urothelial neoplasm of low malignant potential and low grade carcinoma, the discrepancies were 50% after education compared with 39% before education. In contrast, there were no discrepancies when the discrimination was between papillary urothelial neoplasm of low malignant potential and high grade carcinoma or carcinoma in situ. Eliminating categories with poor reproducibility markedly improved the likelihood of unanimous agreement among practitioners but a probably irreducible level of 10% discrepancies remained.
CONCLUSIONS: The 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms requires certain discriminations that cannot be reliably made by practitioners. Modifying the scheme to create categories of low grade neoplasm and high grade carcinoma would markedly increase its practical value to patients without significantly altering patient care.

Entities:  

Mesh:

Year:  2002        PMID: 12187201     DOI: 10.1097/01.ju.0000024393.13257.3b

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Surgical management of bladder transitional cell carcinoma in a vesicular diverticulum: case report.

Authors:  Omer A Raheem; Behdad Besharatian; David P Hickey
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

2.  Reproductibilité des classifications OMS 1973 et OMS 2004 des tumeurs urothéliales papillaires de la vessie.

Authors:  Soumaya Ben Abdelkrim; Soumaya Rammeh; Amel Trabelsi; Lilia Ben Yacoub-Abid; Nabil Ben Sorba; Lilia Jaïdane; Moncef Mokni
Journal:  Can Urol Assoc J       Date:  2011-09-08       Impact factor: 1.862

3.  Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.

Authors:  Burçin Tuna; Kutsal Yörükoglu; Ender Düzcan; Sait Sen; Nalan Nese; Banu Sarsık; Aysegul Akder; Sehnaz Sayhan; Uğur Mungan; Ziya Kirkali
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

Review 4.  Contemporary management of low-risk bladder cancer.

Authors:  Johannes Falke; J Alfred Witjes
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 5.  Expression profiling for bladder cancer: strategies to uncover prognostic factors.

Authors:  Georg Bartsch; Anirban P Mitra; Richard J Cote
Journal:  Expert Rev Anticancer Ther       Date:  2010-12       Impact factor: 4.512

6.  Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.

Authors:  Faysal A Yafi; Armen G Aprikian; Joseph L Chin; Yves Fradet; Jonathan Izawa; Eric Estey; Adrian Fairey; Ricardo Rendon; Ilias Cagiannos; Louis Lacombe; Jean-Baptiste Lattouf; Fred Saad; David Bell; Darrel Drachenberg; Wassim Kassouf
Journal:  World J Urol       Date:  2013-11-10       Impact factor: 4.226

7.  Three-gene signature predicts disease progression of non-muscle invasive bladder cancer.

Authors:  Pildu Jeong; Yun-Sok Ha; In-Chang Cho; Seok-Joong Yun; Eun Sang Yoo; Isaac Yi Kim; Yung Hyun Choi; Sung-Kwon Moon; Wun-Jae Kim
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

Review 8.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

9.  Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer.

Authors:  Rou Wang; David S Morris; Scott A Tomlins; Robert J Lonigro; Alexander Tsodikov; Rohit Mehra; Thomas J Giordano; L Priya Kunju; Cheryl T Lee; Alon Z Weizer; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

10.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.